MetLife Inc., US59156R1086

MetLife stock (US59156R1086): JPMorgan, Jefferies lift price targets

12.05.2026 - 17:56:15 | ad-hoc-news.de

JPMorgan raised its MetLife price target to $96 from $95 while maintaining an Overweight rating, as Jefferies hiked its target to $97 from $92. The moves come amid a consensus mean target of $91.60.

MetLife Inc., US59156R1086
MetLife Inc., US59156R1086

MetLife stock drew attention from Wall Street analysts on May 12, 2026, with JPMorgan adjusting its price target upward to $96 from $95 and keeping an Overweight rating, according to MT Newswires as of 05/12/2026. Separately, Jefferies & Co lifted its target to $97 from $92, reflecting positive sentiment in the insurance sector. MetLife shares traded at $77.58, down 0.50, with an average analyst rating of Overweight and a mean price target of $91.60 per FactSet data, as noted by Marketscreener as of 05/12/2026.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: MetLife, Inc.
  • Sector/industry: Insurance
  • Headquarters/country: United States
  • Core markets: United States (71.6% of premiums), Japan, other
  • Key revenue drivers: Life insurance (63.4%), accident/health (36%)
  • Home exchange/listing venue: NYSE (MET)
  • Trading currency: USD

Official source

For first-hand information on MetLife, visit the company’s official website.

Go to the official website

MetLife: core business model

MetLife, Inc. operates as one of the leading American insurance groups, focusing on life insurance, accident and health coverage, and a smaller property and casualty segment. Premiums break down with life insurance at 63.4%, including savings, pre-planning, and annuities policies, while accident and health insurance accounts for 36%, per company data cited in recent reports. Geographically, the US generates 71.6% of premiums, followed by Japan at 8.1% and other regions at 20.3%.

The company serves individual and group customers through a network of agents, brokers, and digital channels, emphasizing protection products tailored to diverse demographics. This model positions MetLife strongly in the US market, where it holds significant exposure relevant to American investors tracking insurance sector stability.

Main revenue and product drivers for MetLife

Life insurance remains the primary revenue driver, encompassing term life, whole life, and universal life policies alongside annuities for retirement planning. Accident and health products cover group benefits, disability, and supplemental health insurance, catering to employer-sponsored plans popular in the US corporate sector. Recent analyst updates highlight sustained demand in these areas amid economic recovery.

MetLife also engages in corporate initiatives like its partnership with Global Citizen for a FIFA education fund, donating $5 per soccer-juggling video up to $100,000, as reported by StockTitan. Such efforts underscore brand engagement while core premiums drive financial performance.

Industry trends and competitive position

The US insurance industry faces interest rate fluctuations and regulatory changes, yet MetLife's scale provides a competitive edge with diversified geographic and product exposure. Shares traded at $76.84 with a market cap of $49.78 billion and P/E ratio of 15.10, per Robinhood data, positioning it attractively relative to peers.

Why MetLife matters for US investors

With 71.6% of premiums from the US, MetLife offers direct exposure to the American economy's health insurance and retirement savings trends. Its NYSE listing (MET) and role in group benefits make it a key holding for portfolios focused on financial services stability amid US market volatility.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Recent analyst price target increases from JPMorgan and Jefferies signal optimism for MetLife amid its strong US-centric premium base and diversified insurance offerings. The stock's valuation metrics and market position warrant monitoring by US investors, balanced against sector risks like rate changes. Ongoing developments will shape its trajectory.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis MetLife Inc. Aktien ein!

<b>So schätzen die Börsenprofis  MetLife Inc. Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US59156R1086 | METLIFE INC. | boerse | 69315636 |